Ignite Creation Date:
2024-05-05 @ 5:28 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00462423
Status:
COMPLETED
Last Update Posted:
2014-01-08
First Post:
2007-04-18
Brief Title:
Abraxane and Avastin as Therapy for Patients With Malignant Melanoma a Phase II Study
Sponsor:
Lynn E Spitler MD
Organization:
Northern California Melanoma Center
Organization Data
Organization:
Northern California Melanoma Center
Class:
OTHER
Study ID:
070223
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lynn E Spitler MD
Lead Sponsor Class:
OTHER
Responsible Party:
Lynn E Spitler MD
Responsible Party Title:
Director
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Northern California Melanoma Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |
| Celgene Corporation | INDUSTRY |